FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083842334> ?p ?o ?g. }

• W2083842334 endingPage "525" @default.
• W2083842334 startingPage "525" @default.
• W2083842334 abstract "Cardiovascular disease (CVD) is the leading cause of death in the US. Despite the decline in CVD-associated mortality rates in recent years, coronary heart disease (CHD) still causes one in every six deaths in this country. Because most CHD risk factors are modifiable (eg, smoking, hypertension, obesity, onset of type 2 diabetes, and dyslipidemia), cardiovascular risk can be reduced by timely and appropriate interventions, such as smoking cessation, diet and lifestyle changes, and lipid-modifying therapy. Dyslipidemia, manifested by elevated low-density lipoprotein cholesterol (LDL-C), is central to the development and progression of atherosclerosis, which can be silent for decades before triggering a first major cardiovascular event. Consequently, dyslipidemia has become a primary target of intervention in strategies for the prevention of cardiovascular events. The guidelines of the Adult Treatment Panel (ATP) III, updated in 2004, recommend therapeutic lifestyle changes and the use of lipid-lowering medications, such as statins, to achieve specific LDL-C goals based on a person's global cardiovascular risk. For high-risk individuals, such as patients with CHD and diabetic patients without CHD, an LDL-C target of < 100 mg/dL is recommended, and statin therapy should be considered to help patients achieve this goal. If correctly dosed in appropriate patients, currently approved statins are generally safe and provide significant cardiovascular benefits in diverse populations, including women, the elderly, and patients with diabetes. A recent primary prevention trial also showed that statins benefit individuals traditionally not considered at high risk of CHD, such as those with no hyperlipidemia but elevated C-reactive protein. Additional evidence suggests that statins may halt or slow atherosclerotic disease progression. Recent evidence confirms the pivotal role of statins in primary and secondary prevention." @default.
• W2083842334 created "2016-06-24" @default.
• W2083842334 creator A5007074446 @default.
• W2083842334 date "2011-08-01" @default.
• W2083842334 modified "2023-09-25" @default.
• W2083842334 title "Lipid-lowering therapy: who can benefit" @default.
• W2083842334 cites W120848922 @default.
• W2083842334 cites W1224944581 @default.
• W2083842334 cites W1500963439 @default.
• W2083842334 cites W1502524639 @default.
• W2083842334 cites W156853490 @default.
• W2083842334 cites W1816597323 @default.
• W2083842334 cites W184028435 @default.
• W2083842334 cites W1968240228 @default.
• W2083842334 cites W1968809852 @default.
• W2083842334 cites W1969054950 @default.
• W2083842334 cites W1974768421 @default.
• W2083842334 cites W1990763296 @default.
• W2083842334 cites W2031185570 @default.
• W2083842334 cites W2040462758 @default.
• W2083842334 cites W2071891597 @default.
• W2083842334 cites W2097303364 @default.
• W2083842334 cites W2098660853 @default.
• W2083842334 cites W2102026512 @default.
• W2083842334 cites W2102045006 @default.
• W2083842334 cites W2104761168 @default.
• W2083842334 cites W2106343349 @default.
• W2083842334 cites W2107295258 @default.
• W2083842334 cites W2109595108 @default.
• W2083842334 cites W2110601215 @default.
• W2083842334 cites W2115169717 @default.
• W2083842334 cites W2116045728 @default.
• W2083842334 cites W2118310760 @default.
• W2083842334 cites W2126452437 @default.
• W2083842334 cites W2126563293 @default.
• W2083842334 cites W2126678006 @default.
• W2083842334 cites W2133977883 @default.
• W2083842334 cites W2134120087 @default.
• W2083842334 cites W2135631433 @default.
• W2083842334 cites W2146228563 @default.
• W2083842334 cites W2150278133 @default.
• W2083842334 cites W2155121555 @default.
• W2083842334 cites W2159449551 @default.
• W2083842334 cites W2162430779 @default.
• W2083842334 cites W2163014518 @default.
• W2083842334 cites W2164324917 @default.
• W2083842334 cites W2165884492 @default.
• W2083842334 cites W2166213644 @default.
• W2083842334 cites W2166910397 @default.
• W2083842334 cites W2168628873 @default.
• W2083842334 cites W2198678228 @default.
• W2083842334 cites W2247997571 @default.
• W2083842334 cites W2411291173 @default.
• W2083842334 cites W3022401702 @default.
• W2083842334 doi "https://doi.org/10.2147/vhrm.s23113" @default.
• W2083842334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3166192" @default.
• W2083842334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21915170" @default.
• W2083842334 hasPublicationYear "2011" @default.
• W2083842334 type Work @default.
• W2083842334 sameAs 2083842334 @default.
• W2083842334 citedByCount "34" @default.
• W2083842334 countsByYear W20838423342012 @default.
• W2083842334 countsByYear W20838423342013 @default.
• W2083842334 countsByYear W20838423342014 @default.
• W2083842334 countsByYear W20838423342015 @default.
• W2083842334 countsByYear W20838423342016 @default.
• W2083842334 countsByYear W20838423342017 @default.
• W2083842334 countsByYear W20838423342018 @default.
• W2083842334 countsByYear W20838423342020 @default.
• W2083842334 countsByYear W20838423342021 @default.
• W2083842334 countsByYear W20838423342022 @default.
• W2083842334 countsByYear W20838423342023 @default.
• W2083842334 crossrefType "journal-article" @default.
• W2083842334 hasAuthorship W2083842334A5007074446 @default.
• W2083842334 hasBestOaLocation W20838423341 @default.
• W2083842334 hasConcept C126322002 @default.
• W2083842334 hasConcept C134018914 @default.
• W2083842334 hasConcept C177713679 @default.
• W2083842334 hasConcept C1862650 @default.
• W2083842334 hasConcept C2776839432 @default.
• W2083842334 hasConcept C2778096610 @default.
• W2083842334 hasConcept C2779091943 @default.
• W2083842334 hasConcept C2779134260 @default.
• W2083842334 hasConcept C511355011 @default.
• W2083842334 hasConcept C555293320 @default.
• W2083842334 hasConcept C71924100 @default.
• W2083842334 hasConceptScore W2083842334C126322002 @default.
• W2083842334 hasConceptScore W2083842334C134018914 @default.
• W2083842334 hasConceptScore W2083842334C177713679 @default.
• W2083842334 hasConceptScore W2083842334C1862650 @default.
• W2083842334 hasConceptScore W2083842334C2776839432 @default.
• W2083842334 hasConceptScore W2083842334C2778096610 @default.
• W2083842334 hasConceptScore W2083842334C2779091943 @default.
• W2083842334 hasConceptScore W2083842334C2779134260 @default.
• W2083842334 hasConceptScore W2083842334C511355011 @default.
• W2083842334 hasConceptScore W2083842334C555293320 @default.
• W2083842334 hasConceptScore W2083842334C71924100 @default.
• W2083842334 hasLocation W20838423341 @default.

• next